119 related articles for article (PubMed ID: 35501628)
1. Effect of a Predictive Analytics-Targeted Program in Patients on Opioids: a Stepped-Wedge Cluster Randomized Controlled Trial.
Strombotne KL; Legler A; Minegishi T; Trafton JA; Oliva EM; Lewis ET; Sohoni P; Garrido MM; Pizer SD; Frakt AB
J Gen Intern Med; 2023 Feb; 38(2):375-381. PubMed ID: 35501628
[TBL] [Abstract][Full Text] [Related]
2. Effect of a Veterans Health Administration mandate to case review patients with opioid prescriptions on mortality among patients with opioid use disorder: a secondary analysis of the STORM randomized control trial.
Auty SG; Barr KD; Frakt AB; Garrido MM; Strombotne KL
Addiction; 2023 May; 118(5):870-879. PubMed ID: 36495477
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of policy and risk targeting for opioid-related risk mitigation: a randomised programme evaluation with stepped-wedge design.
Minegishi T; Garrido MM; Pizer SD; Frakt AB
BMJ Open; 2018 Jun; 8(6):e020097. PubMed ID: 29950460
[TBL] [Abstract][Full Text] [Related]
4. Differences in adverse outcomes across race and ethnicity among Veterans with similar predicted risks of an overdose or suicide-related event.
Garrido MM; Legler A; Strombotne KL; Frakt AB
Pain Med; 2024 Feb; 25(2):125-130. PubMed ID: 37738604
[TBL] [Abstract][Full Text] [Related]
5. Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide.
Oliva EM; Bowe T; Tavakoli S; Martins S; Lewis ET; Paik M; Wiechers I; Henderson P; Harvey M; Avoundjian T; Medhanie A; Trafton JA
Psychol Serv; 2017 Feb; 14(1):34-49. PubMed ID: 28134555
[TBL] [Abstract][Full Text] [Related]
6. Randomized program evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM): A research and clinical operations partnership to examine effectiveness.
Minegishi T; Frakt AB; Garrido MM; Gellad WF; Hausmann LRM; Lewis ET; Pizer SD; Trafton JA; Oliva EM
Subst Abus; 2019; 40(1):14-19. PubMed ID: 30620691
[TBL] [Abstract][Full Text] [Related]
7. Protocol for evaluating the nationwide implementation of the VA Stratification Tool for Opioid Risk Management (STORM).
Chinman M; Gellad WF; McCarthy S; Gordon AJ; Rogal S; Mor MK; Hausmann LRM
Implement Sci; 2019 Jan; 14(1):5. PubMed ID: 30658658
[TBL] [Abstract][Full Text] [Related]
8. Randomized Policy Evaluation of the Veterans Health Administration Stratification Tool for Opioid Risk Mitigation (STORM).
Minegishi T; Garrido MM; Lewis ET; Oliva EM; Pizer SD; Strombotne KL; Trafton JA; Tenso K; Sohoni PS; Frakt AB
J Gen Intern Med; 2022 Nov; 37(14):3746-3750. PubMed ID: 35715661
[TBL] [Abstract][Full Text] [Related]
9. Impact of Mandated Case Review Policy on Opioid Discontinuation and Mortality Among High-Risk Long-Term Opioid Therapy Patients: The STORM Stepped-Wedge Cluster Randomized Controlled Trial.
Li Y; Barr KD; Trafton JA; Oliva EM; Garrido MM; Frakt AB; Strombotne KL
Subst Abus; 2023 Oct; 44(4):292-300. PubMed ID: 37830514
[TBL] [Abstract][Full Text] [Related]
10. Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration.
Sandbrink F; Oliva EM; McMullen TL; Aylor AR; Harvey MA; Christopher ML; Cunningham F; Minegishi T; Emmendorfer T; Perry JM
J Gen Intern Med; 2020 Dec; 35(Suppl 3):927-934. PubMed ID: 33196968
[TBL] [Abstract][Full Text] [Related]
11. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation.
Oliva EM; Bowe T; Manhapra A; Kertesz S; Hah JM; Henderson P; Robinson A; Paik M; Sandbrink F; Gordon AJ; Trafton JA
BMJ; 2020 Mar; 368():m283. PubMed ID: 32131996
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients.
Zedler B; Xie L; Wang L; Joyce A; Vick C; Kariburyo F; Rajan P; Baser O; Murrelle L
Pain Med; 2014 Nov; 15(11):1911-29. PubMed ID: 24931395
[TBL] [Abstract][Full Text] [Related]
13. Long-term Psychoactive Medications, Polypharmacy, and Risk of Suicide and Unintended Overdose Death Among Midlife and Older Women Veterans.
Gibson CJ; Li Y; Jasuja GK; Keyhani S; Byers AL
J Gen Intern Med; 2022 Sep; 37(Suppl 3):770-777. PubMed ID: 36042093
[TBL] [Abstract][Full Text] [Related]
14. Overdose risk for veterans receiving opioids from multiple sources.
Jasuja GK; Ameli O; Miller DR; Land T; Bernson D; Rose AJ; Berlowitz DR; Smelson DA
Am J Manag Care; 2018 Nov; 24(11):536-540. PubMed ID: 30452210
[TBL] [Abstract][Full Text] [Related]
15. Tracking implementation strategies in the randomized rollout of a Veterans Affairs national opioid risk management initiative.
Rogal SS; Chinman M; Gellad WF; Mor MK; Zhang H; McCarthy SA; Mauro GT; Hale JA; Lewis ET; Oliva EM; Trafton JA; Yakovchenko V; Gordon AJ; Hausmann LRM
Implement Sci; 2020 Jun; 15(1):48. PubMed ID: 32576214
[TBL] [Abstract][Full Text] [Related]
16. Tracking the randomized rollout of a Veterans Affairs opioid risk management tool: A multi-method implementation evaluation using the Consolidated Framework for Implementation Research (CFIR).
McCarthy SA; Chinman M; Rogal SS; Klima G; Hausmann LRM; Mor MK; Shah M; Hale JA; Zhang H; Gordon AJ; Gellad WF
Implement Res Pract; 2022; 3():26334895221114665. PubMed ID: 37091078
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an opioid risk mitigation initiative for veterans undergoing hip or knee arthroplasty at San Francisco Veterans Affairs Health Care System.
Rife T; Tat C; Malakootian M
Am J Health Syst Pharm; 2021 Feb; 78(4):336-344. PubMed ID: 33354703
[TBL] [Abstract][Full Text] [Related]
18. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
